tm logo
BIOCURC
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE

failure to respond or late response

on 17 Sep 2020

Last Applicant/ Owned by

950 E. State Highway 114, Suite 160

Southlake

TX

76092

Serial Number

88197617 filed on 16th Nov 2018

Registration Number

N/A

Correspondent Address

Andrew D. Price

Andrew D. Price

P.O. BOX 34385

Washington DC 20043-9998

Filing Basis

1. use application currently

Disclaimer

NO DATA

BIOCURC

dietary and nutritional supplements, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; ingredients for dietary and nutritional supplements, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; dietary and nutritional supplements fe Read More

Classification Information


Class [005]
Pharmaceutical Products


dietary and nutritional supplements, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; ingredients for dietary and nutritional supplements, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; dietary and nutritional supplements featuring an ingredient whose primary purpose is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; medicated topical creams, gels, salves, sprays, powders, balms and ointments, all for use on the skin, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; ingredients used for further manufacture of topical creams, gels, salves, sprays, powders, balms and ointments, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; medicated topical creams, gels, salves, sprays, powders, balms and ointments, all for use on the skin, featuring an ingredient whose primary purpose is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; pharmaceutical preparations for reducing inflammation, relieving aches and pains, and reducing the risk of disease; ingredients for pharmaceuticals; pharmaceutical preparations featuring an ingredient whose primary purpose is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; dietetic foods adapted for medical use, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; dietetic beverages adapted for medical use, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease; dietetic beverages adapted for medical use featuring an ingredient whose primary purpose is to reduce inflammation, relieve aches and pains, improve overall health and reduce the risk of disease

Mark Details


Serial Number

No 88197617

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 461993

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

Yes

No Basis

No

Design Code(s)

10.09.01 -

Medicines and nonmedical products in tablet, capsule or powder form; suppositories

26.01.21 -

Circles that are totally or partially shaded

26.01.31 -

Five or more circles

27.03.05 -

Representations of objects forming letters or numerals, including punctuation

Legal History


Show more

Status DateAction Taken
17th Sep 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
17th Sep 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
06th Mar 2020FINAL REFUSAL E-MAILED
06th Mar 2020NOTIFICATION OF FINAL REFUSAL EMAILED
06th Mar 2020FINAL REFUSAL WRITTEN
06th Mar 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
06th Mar 2020TEAS/EMAIL CORRESPONDENCE ENTERED
02th Mar 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
29th Aug 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
29th Aug 2019NON-FINAL ACTION E-MAILED